经CCTA量化的角周周炎症和脂蛋白 (a):在非阻塞性CAD中的联合预测值
Xueqiao Yang1, Bowen Li1, Huiyu Chen1
1Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, Shandong 250117, China; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
International journal of cardiology
|September 10, 2025
概括
结合脂蛋白 (a) (Lp(a)) 和周冠状腺脂肪组织衰减 (PCATa),可显著改善非阻塞性冠状动脉疾病 (CAD) 患者主要心血管不良事件 (MACE) 的预测. 这种方法为心血管结果提供了增强的风险分层.
科学领域:
- 心血管成像和诊断系统
- 动脉样硬化中的生物标志物
- 心脏病学中的预测建模.
背景情况:
- 非阻塞性冠状动脉疾病 (CAD) 仍然存在重大不良心血管事件 (MACE) 的风险.
- 传统的风险因素可能无法完全捕捉这些患者的风险.
- 需要新的成像和血清学标记物来改善风险分层.
研究的目的:
- 评估MACEs的冠状周脂肪组织衰减 (PCATa) 和脂蛋白 (a) (Lp(a)) 的联合预测值.
- 评估PCATa,Lp(a) 和动脉样硬化负担之间的关联.
- 为了确定这些标记物的结合是否可以提高MACE在非阻塞性CAD中的预测.
主要方法:
- 对1052名非阻塞性CAD患者的分析.
- 冠状动脉计算机断层扫描血管学 (CCTA) 用于PCATa评估.
- 测量血清Lp (a) 的水平.
- 对MACE (心肌梗塞,心力衰竭,中风,死亡率,再血管化) 的纵向随访.
主要成果:
- 17.4%的患者在平均6.8年的随访期间经历了MACE.
- 升高的Lp(a) 和PCATa与MACE显著相关 (P<0.001).
- 结合的Lp(a) 和PCATa显示了MACEs的最高预测精度 (AUC).
结论:
- 结合Lp(a) 和PCATa可显著改善非阻塞性CAD中MACE的预测.
- 较高的Lp(a) 水平与PCATa的增加相关,这表明有共同的病理生理联系.
- 这种综合标记方法为加强心血管风险评估提供了一个有希望的工具.
相关概念视频
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
401
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
401
01:30Acute Coronary Syndrome III: Diagnostic Studies
219
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219
01:30Coronary Artery Disease I: Introduction
893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:26Coronary Artery Disease IV: Preventive Measures
591
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591
01:26Coronary Artery Disease II: Pathophysiology
376
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376